Pharmaphie SDW SRL
1.3 FTEThe score of Pharmaphie SDW shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +30 % Total assets +7 % Headcount (avg FTE) -7 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmaphie SDW's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 22 Jun 2026
- Year ended 31 Dec 2024filed on 16 Jul 2025
- Year ended 31 Dec 2023filed on 01 Jul 2024
- Year ended 31 Dec 2022filed on 03 Jul 2023
- Year ended 31 Dec 2021filed on 07 Jul 2022
Pharmaphie SDW's financial analysis
- Solvency35.5%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmaphie SDW
Pharmaphie SDW's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0848.603.510
- VAT number
- BE0848603510
- Peppol
- Registered · 0208:0848603510 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 07 Sep 2012
- Registered office
- 9051 Ghent
- Size
- Micro · 1.3 FTE
- Latest accounts
- 2025 · filed on 22 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharmaphie SDW (SRL) has been based in Ghent since 2012, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 3,946 € and equity of 421,867 €; its revenue is not published. With 1.3 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 35.5%, below the median of its sector (44.2%).
Companies similar to Pharmaphie SDW
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Pharmago Retail sale of pharmaceutical products Nazareth-De Pinte · balance sheet €1.20m
- Pharmacie Jassogne Retail sale of pharmaceutical products Faimes · balance sheet €1.19m
- MPL Pharma Retail sale of pharmaceutical products Ciney · balance sheet €1.05m
- Medigrex Retail sale of pharmaceutical products Wuustwezel · balance sheet €1.18m
- Brugafar Retail sale of pharmaceutical products Nieuwpoort · balance sheet €1.18m
- Pharmabrussels Flagey Retail sale of pharmaceutical products Ixelles · balance sheet €1.20m
- Dalemans Retail sale of pharmaceutical products Buggenhout · balance sheet €1.20m
- Diximo Retail sale of pharmaceutical products Ferrières · balance sheet €1.20m
Frequently asked questions about Pharmaphie SDW
What is the revenue of Pharmaphie SDW?
Pharmaphie SDW files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharmaphie SDW?
In Belgium, the VAT number is the company number prefixed with BE: BE0848603510 for Pharmaphie SDW, if the company is VAT-registered. Its company number (CBE) is 0848.603.510.
Where is the registered office of Pharmaphie SDW?
According to the CBE register, the registered office of Pharmaphie SDW is in 9051 Ghent.
What is the equity of Pharmaphie SDW?
At the close of the 2025 financial year, the equity of Pharmaphie SDW amounts to 421,867 €, a solvency of 35.5% of total assets.
How many people work at Pharmaphie SDW?
1.3 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Pharmaphie SDW?
The register lists 3 active mandates at Pharmaphie SDW. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmaphie SDW
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →